CD8A and neoplasm: Activation of the STING pathway by intratumoral (IT) injection of synthetic cyclic dinucleotides (CDNs) induces type I interferons in tumor resident-myeloid subsets, activation of antigen presenting cells, expansion of tumor-specific CD8+ T cells and control of tumors [5,6,7].